Wells Fargo & Company Edwards Lifesciences Corp Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wells Fargo & Company holds 762,879 shares of EW stock, worth $53.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

762,879

Previous 852,879 10.55%

Holding current value

$53.8 Million

Previous $78.8 Million 36.1%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $5.37 Million - $8.44 Million	-90,000 Reduced 10.55%	762,879 $50.3 Million
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $2.58 Million - $2.89 Million	30,655 Added 3.73%	852,879 $78.8 Million
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $9.75 Million - $12.8 Million	134,400 Added 19.54%	822,224 $78.6 Million
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $1.23 Million - $1.55 Million	19,893 Added 2.98%	687,824 $52.4 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $16 Million - $21.6 Million	-231,338 Reduced 25.73%	667,931 $46.3 Million
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $3.04 Million - $3.53 Million	37,382 Added 4.34%	899,269 $84.8 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $3.77 Million - $4.29 Million	-50,760 Reduced 5.56%	861,887 $71.3 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $7.81 Million - $10 Million	-114,414 Reduced 11.14%	912,647 $68.1 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $16 Million - $20.9 Million	-194,504 Reduced 15.92%	1,027,061 $84.9 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $12.7 Million - $18.8 Million	-146,801 Reduced 10.73%	1,221,565 $116 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $482,270 - $607,048	-4,730 Reduced 0.34%	1,368,366 $161 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $299 Million - $367 Million	-2,809,638 Reduced 67.17%	1,373,096 $178 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $49.9 Million - $59.5 Million	-484,710 Reduced 10.38%	4,182,734 $474 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $11.9 Million - $14.8 Million	-141,498 Reduced 2.94%	4,667,444 $483 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $3.95 Million - $4.56 Million	-50,252 Reduced 1.03%	4,808,942 $402 Million
Q4 2020 Feb 09, 2021	BUY	$71.69 - $91.23 $17.5 Million - $22.2 Million	243,707 Added 5.28%	4,859,194 $443 Million
Q3 2020 Nov 05, 2020	BUY	$67.19 - $87.44 $5.47 Million - $7.12 Million	81,391 Added 1.8%	4,615,487 $368 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $186 Million - $248 Million	3,226,165 Added 246.66%	4,534,096 $313 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $68.5 Million - $106 Million	1,307,931 New	1,307,931 $247 Million

Others Institutions Holding EW

# of Institutions

1,349

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Edwards Lifesciences Corp Transaction History